Literature DB >> 24728159

Challenges and pitfalls in the diagnosis of hyperprolactinemia.

Lucio Vilar1, Maria Fleseriu2, Marcello D Bronstein3.   

Abstract

The definition of the etiology of hyperprolactinemia often represents a great challenge and an accurate diagnosis is paramount before treatment. Although prolactin levels > 200-250 ng/mL are highly suggestive of prolactinomas, they can occasionally be found in other conditions. Moreover, as much as 25% of patients with microprolactinomas may present prolactin levels < 100 ng/mL, which are found in most patients with pseudoprolactinomas, drug-induced hyperprolactinemia, or systemic diseases. On the other hand, some conditions may lead to falsely low PRL levels, particularly the so-called hook effect, that is an assay artifact caused by an extremely high level of PRL, and can be confirmed by repeating assay after a 1:100 serum sample dilution. The hook effect must be considered in all patients with large pituitary adenomas and PRL levels within the normal range or only modestly elevated (e.g., < 200 ng/mL). An overlooked hook effect may lead to incorrect diagnosis and unnecessary surgical intervention in patients with prolactinomas. Another important challenge is macroprolactinemia, a common finding that needs to be identified, as it usually requires no treatment. Although most macroprolactinemic patients are asymptomatic, many of them may present galactorrhea or menstrual disorders, as well as neuroradiological abnormalities, due to the concomitance of other diseases. Finally, physicians should be aware that pituitary incidentalomas are found in at least 10% of adult population.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24728159     DOI: 10.1590/0004-2730000003002

Source DB:  PubMed          Journal:  Arq Bras Endocrinol Metabol        ISSN: 0004-2730


  13 in total

Review 1.  Diagnosis and treatment of infertility-related male hormonal dysfunction.

Authors:  Martin Kathrins; Craig Niederberger
Journal:  Nat Rev Urol       Date:  2016-04-19       Impact factor: 14.432

Review 2.  Acromegaly: clinical features at diagnosis.

Authors:  Lucio Vilar; Clarice Freitas Vilar; Ruy Lyra; Raissa Lyra; Luciana A Naves
Journal:  Pituitary       Date:  2017-02       Impact factor: 4.107

3.  The effect of short-term metformin treatment on plasma prolactin levels in bromocriptine-treated patients with hyperprolactinaemia and impaired glucose tolerance: a pilot study.

Authors:  Robert Krysiak; Joanna Okrzesik; Boguslaw Okopien
Journal:  Endocrine       Date:  2014-09-20       Impact factor: 3.633

4.  Second Attempt of Cabergoline Withdrawal in Patients with Prolactinomas after a Failed First Attempt: Is it Worthwhile?

Authors:  Lucio Vilar; José Luciano Albuquerque; Patrícia Sampaio Gadelha; Frederico Rangel Filho; Aline Maria C Siqueira; Maíra Melo da Fonseca; Karoline Frazão Viana; Barbara Sales Gomes; Ruy Lyra
Journal:  Front Endocrinol (Lausanne)       Date:  2015-02-04       Impact factor: 5.555

Review 5.  The risks of overlooking the diagnosis of secreting pituitary adenomas.

Authors:  Thierry Brue; Frederic Castinetti
Journal:  Orphanet J Rare Dis       Date:  2016-10-06       Impact factor: 4.123

6.  Prolactinomas Resistant to Treatment With Dopamine Agonists: Long-Term Follow-Up of Six Cases.

Authors:  Maria de Fátima de Magalhães Gonzaga; Lucas Faria de Castro; Luciana Ansaneli Naves; José Luiz Mendonça; Benicio Oton de Lima; Iruena Kessler; Luiz Augusto Casulari
Journal:  Front Endocrinol (Lausanne)       Date:  2018-11-13       Impact factor: 5.555

7.  Aetiologies of Hyperprolactinaemia: A retrospective analysis from a tertiary healthcare centre.

Authors:  Azhar A Malik; Faisal Aziz; Salem A Beshyah; Khaled M Aldahmani
Journal:  Sultan Qaboos Univ Med J       Date:  2019-09-08

8.  Serum prolactin overestimation and risk of misdiagnosis.

Authors:  Sunita M C De Sousa; Mohamed Saleem; Wayne Rankin; David J Torpy
Journal:  Endocrinol Diabetes Metab       Date:  2019-03-23

Review 9.  Hyperprolactinaemia.

Authors:  Irene Samperi; Kirstie Lithgow; Niki Karavitaki
Journal:  J Clin Med       Date:  2019-12-13       Impact factor: 4.241

10.  Gigantomastia and Macroprolactinemia Responding to Cabergoline Treatment: A Case Report and Minireview of the Literature.

Authors:  Fatma Dilek Dellal; Didem Ozdemir; Cevdet Aydin; Gulfem Kaya; Reyhan Ersoy; Bekir Cakir
Journal:  Case Rep Endocrinol       Date:  2016-04-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.